Completing an initial public offering ought to be a big step in company development. It is a departure from a cosseted, insulated environment of unique technical approaches and regulatory progress and
Company Changes BAIN , Linda To: Codiak BioSciences Inc. , CFO (January) From: Avalanche Biotechnologies Inc., CFO Phone: 617-716-9107 BAKEWELL , John K. To: Exact Sciences Corp. , CFO (Ja
Company Changes COOPER , Todd To: Presbia PLC , Pres. & CEO (January) From: NVISION Laser Eye Centers, VP, General Mgr. Phone: 949-502-7010 DI RUSSO , Gregory B., MD To: CytoSorbents Corp.